Silk Road Medical (NASDAQ:SILK – Free Report) had its price target cut by Piper Sandler from $25.00 to $11.00 in a research report sent to investors on Wednesday, Benzinga reports. They currently have a neutral rating on the stock. Several other research analysts have also weighed in on the company. Stifel Nicolaus lowered Silk Road […]
Silk Road Medical (NASDAQ:SILK – Get Rating) had its target price decreased by Argus from $70.00 to $55.00 in a research report issued on Monday, The Fly reports. Argus’ price target points to a potential upside of 74.49% from the stock’s current price. SILK has been the topic of several other reports. Piper Sandler decreased […]
Silk Road Medical, Inc (NASDAQ:SILK – Get Rating) CFO Lucas W. Buchanan sold 41,244 shares of the firm’s stock in a transaction that occurred on Thursday, January 19th. The stock was sold at an average price of $53.40, for a total transaction of $2,202,429.60. Following the sale, the chief financial officer now directly owns 188,811 […]